Auxiliary factors: A chink in the armor of MRSA resistance to β-lactam antibiotics

Current Opinion in Microbiology

Volumn 16, Issue 5, 2013, Pages 538-548

  Roemer, Terry ^a   Schneider, Tanja ^b,c   Pinho, Mariana G ^d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AUXILIARY FACTOR; BAMBERMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BIOLOGICAL FACTOR; CEFOXITIN; CEFTOBIPROLE; CYCLOSERINE; FOSFOMYCIN; IMIPENEM; MOENOMYCIN A; OXACILLIN; STREPTOVIRUDIN; TEICHOIC ACID; TUNICAMYCIN; UNCLASSIFIED DRUG;

AMIDATION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL CELL WALL; BACTERIAL GENETICS; BACTERIAL VIRULENCE; BINDING AFFINITY; BIOGENESIS; BIOSYNTHESIS; CELL DIVISION; CELL STRESS; CELL SURFACE; CELL VIABILITY; CYTOKINESIS; DRUG EFFICACY; DRUG POTENTIATION; DRUG TARGETING; DRUG TOLERANCE; ENZYME ACTIVITY; EXTRACELLULAR SPACE; GLYCOSYLATION; HOSPITAL INFECTION; INCIDENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS SCIURI;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; DRUG DISCOVERY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PENICILLIN-BINDING PROTEINS;

EID: 84887624623     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.06.012     Document Type: Review

References (99)

1. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., Harrison L.H., Lynfield R., Dumyati G., Townes J.M., et al. Active Bacterial Core surveillance (ABCs) MRSA Investigators. JAMA 2007, 298:1763-1771.
2. Boucher H.W., Talbot G.H., Bradley J.S., Edwards J.E., Gilbert D., Rice L.B., Scheld M., Spellberg B., Bartlett J. Bad bugs, no drugs:no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1-12.
3. Styers D., Sheehan D.J., Hogan P., Sahm D.F. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among 24 Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006, 5:1-9.
4. Brink A.J. Does resistance in severe infections caused by methicillin-resistant Staphylococcus aureus give you the 'creeps'?. Curr Opin Crit Care 2012, 18:451-459.
5. Flamm R.K., Mendes R.E., Ross J.E., Sader H.S., Jones R.N. Linezolid Surveillance Results for the United States: LEADER Surveillance Program 2011. Antimicrob Agents Chemother 2013, 57:1077-1081.
6. Payne D.J., Gwynn M.N., Holmes D.J., Pompliano D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007, 6:29-40.
7. Llarrull L.I., Testero S.A., Fisher J.F., Mobashery S. The future of the β-lactams. Curr Opin Microbiol 2010, 13:551-557.
8. Walsh C. Antibiotics: Actions, Origins Resistance 2003, 345. ASM Press, Washington, DC.
9. Llarrull L.I., Fisher J.F., Mobashery S. Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge. Antimicrob Agents Chemother 2009, 53:4051-4063.
10. de Lencastre H., Oliveira D., Tomasz A. Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Curr Opin Microbiol 2007, 10:428-435.
11. Couto I., de Lencastre H., Severina E., Kloos W., Webster J.A., Hubner R.J., Sanches I.S., Tomasz A. Ubiquitous presence of a mecA homologue in natural isolates of Staphylococcus sciuri. Microb Drug Resist 1996, 2:377-391.
12. Tsubakishita S., Kuwahara-Arai K., Sasaki T., Hiramatsu K. Origin and molecular evolution of the determinant of methicillin resistance in staphylococci. Antimicrob Agents Chemother 2010, 54:4352-4359.
13. Fuda C., Suvorov M., Vakulenko S.B., Mobashery S. The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. J Biol Chem 2004, 279:40802-40806.
14. Fuda C.C., Fisher J.F., Mobashery S. Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome. Cell Mol Life Sci 2005, 62:2617-2633.
15. Pinho M.G., de Lencastre H., Tomasz A. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant Staphylococci. Proc Natl Acad Sci USA 2001, 98:10886-10891.
16. Pinho M.G., Filipe S.R., de Lencastre H., Tomasz A. Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus. J Bacteriol 2001, 183:6525-6531.
17. Scheffers D.J., Pinho M.G. Bacterial cell wall synthesis: new insights from localization studies. Microbiol Mol Biol Rev 2005, 69:585-607.
18. Drawz S.M., Bonomo R.A. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev 2010, 23:160-201.
19. Kalan L., Wright G.D. Antibiotic adjuvants: multicomponent anti-infective strategies. Expert Rev Mol Med 2011, 23(13):e5.
20. Amsterdam D. Susceptibility testing of antimicrobials in liquid media. Antibiotics in Laboratory Medicine 2005, 89-93. Lippincott Williams & Wilkins, Philadelphia, PA. V. Lorian (Ed.).
21. Fritsche T.R., Sader H.S., Jones R.N. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006). Diagn Microbiol Infect Dis 2008, 61:86-95.
22. Berger-Bächi B., Rohrer S. Factors influencing methicillin resistance in Staphylococci. Arch Microbiol 2002, 178:165-171.
23. van Heijenoort J. Recent advances in the formation of the bacterial peptidoglycan monomer unit. Nat Prod Rep 2001, 18:503-519.
24. van Heijenoort J. Lipid intermediates in the biosynthesis of bacterial peptidoglycan. Microbiol Mol Biol Rev 2007, 71:620-635.
25. Rohrer S., Berger-Bächi B. FemABX peptidyl transferases: a link between branched-chain cell wall peptide formation and beta-lactam resistance in gram-positive cocci. Antimicrob Agents Chemother 2003, 47:837-846.
26. Schneider T., Senn M.M., Berger-Bächi B., Tossi A., Sahl H.G., Wiedemann I. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus. Mol Microbiol 2004, 53:675-685.
27. Münch D., Roemer T., Lee S.H., Engeser M., Sahl H.G., Schneider T. Identification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureus. PLoS Pathog 2012, 8:e1002509.
28. Figueiredo T.A., Sobral R.G., Ludovice A.M., Almeida J.M., Bui N.K., Vollmer W., de Lencastre H., Tomasz A. Identification of genetic determinants and enzymes involved with the amidation of glutamic acid residues in the peptidoglycan of Staphylococcus aureus. PLoS Pathog 2012, 8:e1002508.
29. Nakel M., Ghuysen J.M., Kandler O. Wall peptidoglycan in Aerococcus viridans strains 201 Evans and ATCC 11563 and in Gaffkya homari strain ATCC 10400. Biochemistry 1971, 10:2170-2175.
30. Mohammadi T., van Dam V., Sijbrandi R., Vernet T., Zapun A., Bouhss A., Diepeveen-de Bruin M., Nguyen-Distèche M., de Kruijff B., Breukink E. Identification of FtsW as a transporter of lipid-linked cell wall precursors across the membrane. EMBO 2011, 30:1425-1432.
31. Huber J., Donald R.G., Lee S.H., Wang-Jarantow L., Salvatore M.J., Meng X., Painter R., Onishi R.H., Occi J., Dorso K., et al. Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureus. Chem Biol 2009, 16:837-848.
32. Ruiz N. Bioinformatics identification of MurJ (MviN) as the peptidoglycan lipid II flippase in Escherichia coli. Proc Natl Acad Sci USA 2008, 105:15553-15557.
33. de Lencastre H., Tomasz A. Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1994, 38:2590-2598.
34. de Lencastre H., Wu S.W., Pinho M.G., Ludovice A.M., Filipe S., Gardete S., Sobral R., Gill S., Chung M., Tomasz A. Antibiotic resistance as a stress response: complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin. Microb Drug Resist 1999, 5:163-175.
35. Forsyth R.A., Haselbeck R.J., Ohlsen K.L., Yamamoto R.T., Xu H., Trawick J.D., Wall D., Wang L., Brown-Driver V., Froelich J.M., et al. A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol Microbiol 2002, 43:1387-1400.
36. Lee S.H., Wang-Jarantow L., Wang H., Sillaots S., Cheng H., Meredith T.C., Thompson J., Roemer T. Antagonism of chemical genetic interaction networks resensitize MRSA to β-lactam antibiotics. Chem Biol 2011, 18:1379-1389.
37. Blake K.L., O'Neill A.J., Mengin-Lecreulx D., Henderson P.J., Bostock J.M., Dunsmore C.J., Simmons K.J., Fishwick C.W., Leeds J.A., Chopra I. The nature of Staphylococcus aureus MurA and MurZ and approaches for detection of peptidoglycan biosynthesis inhibitors. Mol Microbiol 2009, 72:335-343.
38. Komatsuzawa H., Suzuki J., Sugai M., Miyake Y., Suginaka H. Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1994, 33:1155-1163.
39. Sieradzki K., Tomasz A. Suppression of beta-lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics. J Antimicrob Chemother 1997, 39(Suppl A):47-51.
40. Banerjee R., Fernandez M.G., Enthaler N., Graml C., Greenwood-Quaintance K.E., Patel R. Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 2013, 32:827-833.
41. Memmi G., Filipe S.R., Pinho M.G., Fu Z., Cheung A. Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains. Antimicrob Agents Chemother 2008, 52:3955-3966.
42. Koyama N., Tokura Y., Münch D., Sahl H.G., Schneider T., Shibagaki Y., Ikeda H., Tomoda H. The nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis. PLoS One 2012, 7:e48981.
43. Schneider T., Sahl H.G. An oldie but a goodie-cell wall biosynthesis as antibiotic target pathway. Int J Med Microbiol 2010, 300:161-169.
44. Midorikawa K., Ouhara K., Komatsuzawa H., Kawai T., Yamada S., Fujiwara T., Yamazaki K., Sayama K., Taubman M.A., Kurihara H., et al. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun 2003, 71:3730-3739.
45. Pinho M.G., Errington J. Dispersed mode of Staphylococcus aureus cell wall synthesis in the absence of the division machinery. Mol Microbiol 2003, 50:871-881.
46. Pinho M.G., Errington J. Recruitment of penicillin-binding protein PBP2 to the division site of Staphylococcus aureus is dependent on its transpeptidation substrates. Mol Microbiol 2005, 55:799-807.
47. Adams D.W., Errington J. Bacterial cell division: assembly, maintenance and disassembly of the Z ring. Nat Rev Microbiol 2009, 7:642-653.
48. Tan C.M., Therien A.G., Lu J., Lee S.H., Caron A., Gill C.J., Lebeau-Jacob C., Benton-Perdomo L., Monteiro J.M., Pereira P.M., et al. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics. Sci Transl Med 2012, 4:126ra35.
49. Atilano M.L., Pereira P.M., Yates J., Reed P., Veiga H., Pinho M.G., Filipe S.R. Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus. Proc Natl Acad Sci USA 2010, 107:18991-18996.
50. Maki H., Yamaguchi T., Murakami K. Cloning and characterization of a gene affecting the methicillin resistance level and the autolysis rate in Staphylococcus aureus. J Bacteriol 1994, 176:4993-5000.
51. Campbell J., Singh A.K., Santa Maria J.P., Kim Y., Brown S., Swoboda J.G., Mylonakis E., Wilkinson B., Walker S. Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol 2011, 6:106-116.
52. Swoboda J.G., Campbell J., Meredith T.C., Walker S. Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem 2010, 11:35-45.
53. Weidenmaier C., Peschel A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol 2008, 6:276-287.
54. Weidenmaier C., Kokai-Kun J.F., Kristian S.A., Chanturiya T., Kalbacher H., Gross M., Nicholson G., Neumeister B., Mond J.J., Peschel A. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 2004, 10:243-245.
55. D'Elia M.A., Pereira M.P., Brown E.D. Are essential genes really essential?. Trends Microbiol 2009, 17:433-438.
56. Schirner K., Marles-Wright J., Lewis R.J., Errington J. Distinct and essential morphogenic functions for wall- and lipo-teichoic acids in Bacillus subtilis. EMBO 2009, 28:830-842.
57. Dengler V., Meier P.S., Heusser R., Kupferschmied P., Fazekas J., Friebe S., Staufer S.B., Majcherczyk P.A., Moreillon P., Berger-Bächi B., et al. Deletion of hypothetical wall teichoic acid ligases in Staphylococcus aureus activates the cell wall stress response. FEMS Microbiol Lett 2012, 333:109-120.
58. Brown S., Zhang Y.H., Walker S. A revised pathway proposed for Staphylococcus aureus wall teichoic acid biosynthesis based on in vitro reconstitution of the intracellular steps. Chem Biol 2008, 15:12-21.
59. Schlag M., Biswas R., Krismer B., Kohler T., Zoll S., Yu W., Schwarz H., Peschel A., Götz F. Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl. Mol Microbiol 2010, 75:864-873.
60. D'Elia M.A., Pereira M.P., Chung Y.S., Zhao W., Chau A., Kenney T.J., Sulavik M.C., Black T.A., Brown E.D. Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway. J Bacteriol 2006, 188:4183-4189.
61. D'Elia M.A., Millar K.E., Beveridge T.J., Brown E.D. Wall teichoic acid polymers are dispensable for cell viability in Bacillus subtilis. J Bacteriol 2006, 188:8313-8316.
62. D'Elia M.A., Henderson J.A., Beveridge T.J., Heinrichs D.E., Brown E.D. The N-acetylmannosamine transferase catalyzes the first committed step of teichoic acid assembly in Bacillus subtilis and Staphylococcus aureus. J Bacteriol 2009, 191:4030-4034.
63. Swoboda J.G., Meredith T.C., Campbell J., Brown S., Suzuki T., Bollenbach T., Malhowski A.J., Kishony R., Gilmore M.S., Walker S. Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus. ACS Chem Biol 2009, 4:875-883.
64. Lee K., Campbell J., Swoboda J.G., Cuny G.D., Walker S. Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus. Bioorg Med Chem Lett 2010, 20:1767-1770.
65. Suzuki T., Swoboda J.G., Campbell J., Walker S., Gilmore M.S. In vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates. Antimicrob Agents Chemother 2011, 55:767-774.
66. Schirner K., Stone L.K., Walker S. ABC transporters required for export of wall teichoic acids do not discriminate between different main chain polymers. ACS Chem Biol 2011, 6:407-412.
67. Wang H., Gill C.J., Lee S.H., Mann P., Zuck P., Meredith T.C., Murgolo N., She X., Kales S., Liang L., et al. Discovery of novel wall teichoic acid inhibitors as effective anti-MRSA β-lactam combination agents. Chem Biol 2013, 20:272-284.
68. Campbell J., Singh A.K., Swoboda J.G., Gilmore M.S., Wilkinson B.J., Walker S. An antibiotic that inhibits a late step in wall teichoic acid biosynthesis induces the cell wall stress stimulon in Staphylococcus aureus. Antimicrob Agents Chemother 2012, 56:1810-1820.
69. Rine J., Hansen W., Hardeman E., Davis R.W. Targeted selection of recombinant clones through gene dosage effects. Proc Natl Acad Sci USA 1983, 80:6750-6754.
70. Eckardt K. Tunicamycins, streptovirudins, and corynetoxins, a special subclass of nucleoside antibiotics. J Nat Prod 1983, 46:544-550.
71. Farha M.A., Leung A., Sewell E.W., D'Elia M.A., Allison S.E., Ejim L., Pereira P.M., Pinho M.G., Wright G.D., Brown E.D. Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to β-lactams. ACS Chem Biol 2013, 8:226-233.
72. Brown S., Xia G., Luhachack L.G., Campbell J., Meredith T.C., Chen C., Winstel V., Gekeler C., Irazoqui J.E., Peschel A., et al. Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc Natl Acad Sci USA 2012, 109:18909-18914.
73. Xia G., Maier L., Sanchez-Carballo P., Li M., Otto M., Holst O., Peschel A. Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM. J Biol Chem 2010, 285:13405-13415.
74. Xia G., Kohler T., Peschel A. The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. Int J Med Microbiol 2010, 300:148-154.
75. Gründling A., Schneewind O. Genes required for glycolipid synthesis and lipoteichoic acid anchoring in Staphylococcus aureus. J Bacteriol 2007, 189:2521-2530.
76. Gründling A., Schneewind O. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc Natl Acad Sci USA 2007, 104:8478-8483.
77. Meredith T.C., Wang H., Beaulieu P., Gründling A., Roemer T. Harnessing the power of transposon mutagenesis for antibacterial target identification and evaluation. Mob Genet Elements 2012, 2:171-178.
78. Wörmann M.E., Reichmann N.T., Malone C.L., Horswill A.R., Gründling A. Proteolytic cleavage inactivates the Staphylococcus aureus lipoteichoic acid synthase. J Bacteriol 2011, 193:5279-5291.
79. Therien A.G., Huber J.L., Wilson K.E., Beaulieu P., Caron A., Claveau D., Deschamps K., Donald R.G., Galgoci A.M., Gallant M., et al. Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I. Antimicrob Agents Chemother 2012, 56:4662-4670.
80. Jordan S., Hutchings M.I., Mascher T. Cell envelope stress response in Gram-positive bacteria. FEMS Microbiol Rev 2008, 32:107-146.
81. Kuroda M., Kuroda H., Oshima T., Takeuchi F., Mori H., Hiramatsu K. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol 2003, 49:807-821.
82. Utaida S., Dunman P.M., Macapagal D., Murphy E., Projan S.J., Singh V.K., Jayaswal R.K., Wilkinson B.J. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 2003, 149:2719-2732.
83. Gardete S., Wu S.W., Gill S., Tomasz A. Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Antimicrob Agents Chemother 2006, 50:3424-3434.
84. Sobral R.G., Jones A.E., Des Etages S.G., Dougherty T.J., Peitzsch R.M., Gaasterland T., Ludovice A.M., de Lencastre H., Tomasz A. Extensive and genome-wide changes in the transcription profile of Staphylococcus aureus induced by modulating the transcription of the cell wall synthesis gene murF. J Bacteriol 2007, 189:2376-2391.
85. Jo D.S., Montgomery C.P., Yin S., Boyle-Vavra S., Daum R.S. Improved oxacillin treatment outcomes in experimental skin and lung infection by methicillin-resistant Staphylococcus aureus containing a vraSR operon deletion. Antimicrob Agents Chemother 2011, 55:2818-2823.
86. Beltramini A.M., Mukhopadhyay C.D., Pancholi V. Modulation of cell wall structure and antimicrobial susceptibility by a Staphylococcus aureus eukaryote-like serine/threonine kinase and phosphatase. Infect Immun 2009, 77:406-416.
87. Tamber S., Schwartzman J., Cheung A.L. Role of PknB kinase in antibiotic resistance and virulence in community-acquired methicillin-resistant Staphylococcus aureus strain USA300. Infect Immun 2010, 78:3637-3646.
88. Liebeke M., Meyer H., Donat S., Ohlsen K., Lalk M. A metabolomic view of Staphylococcus aureus and its Ser/Thr kinase and phosphatase deletion mutants: involvement in cell wall biosynthesis. Chem Biol 2010, 17:820-830.
89. Pereira S.F., Goss L., Dworkin J. Eukaryote-like serine/threonine kinases and phosphatases in bacteria. Microbiol Mol Biol Rev 2011, 75:212.
90. Yeats C., Finn R.D., Bateman A. The PASTA domain: a beta-lactam-binding domain. Trends Biochem Sci 2002, 27:438.
91. Débarbouillé M., Dramsi S., Dussurget O., Nahori A.M., Vaganay E., Jouvion G., Cozzone A., Msadek T., Duclos B. Characterization of a serine/threonine kinase involved in virulence of Staphylococcus aureus. J Bacteriol 2009, 191:4070-4081.
92. Goldberg D.E., Siliciano R.F., Jacobs W.R. Outwitting evolution: fighting drug-resistant TB, malaria, and HIV. Cell 2012, 148:1271-1283.
93. Rohrer S., Ehlert K., Tschierske M., Labischinski H., Berger-Bächi B. The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. Proc Natl Acad Sci USA 1999, 96:9351-9356.
94. Strandén A.M., Ehlert K., Labischinski H., Berger-Bächi B. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J Bacteriol 1997, 179:9-16.
95. Henze U., Sidow T., Wecke J., Labischinski H., Berger-Bächi B. Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus. J Bacteriol 1993, 175:1612-1620.
96. Gustafson J., Strässle A., Hächler H., Kayser F.H., Berger-Bächi B. The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon. J Bacteriol 1994, 176:1460-1467.
97. Jolly L., Wu S.W., Van Heijenoort J., De Lencastre H., Mengin Lecreulx D., Tomasz A. The femR315 gene from Staphylococcus aureus, the interruption of which results in reduced methicillin resistance, encodes a phosphoglucosamine mutase. J Bacteriol 1997, 179:5321-5325.
98. Komatsuzawa H., Ohta K., Labischinski H., Sugai M., Suginaka H. Characterization of fmtA, a gene that modulates the expression of methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1999, 43:2121-2125.
99. Wu S., de Lencastre H., Tomasz A. Sigma-B, a putative operon encoding alternate sigma factor of Staphylococcus aureus RNA polymerase: molecular cloning and DNA sequencing. J Bacteriol 1996, 178:6036-6042.